Market Cap

Lonza Group Ltd Market Capitalization:

CHF39.13 Billion

CHF as of July 1, 2023

US$43.73 Billion

business Lonza Group Ltd Company Profile

Lonza Group Ltd Main Stock Listing

show_chart SIX: LONN

Market Capitalization History of Lonza Group Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $199.03 B
Danaher $175.38 B
Siemens Healthineers AG $62.71 B
DexCom, Inc. $49.13 B
IDEXX Laboratories, Inc. $42.74 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Lonza Group Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2023 CHF34.68 B -25.92%
Jan. 1, 2022 CHF46.82 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

flash_on

Unlock the Power of Financial AI:

Try Disfold AI Free for 7 Days!

Lonza Group Ltd Categories

Switzerland languages Healthcare languages Diagnostics & Research
Switzerland Healthcare Switzerland Diagnostics & Research

Stocks & Indices

Lonza Group Ltd has the following listings and related stock indices.


Stock: SIX: LONN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.